STANDBY EQUITY DISTRIBUTION AGREEMENT
-------------------------------------
THIS
AGREEMENT dated as of the 28th day of April
2005 (the "Agreement")
between CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the
"Investor"), and THE CERTO GROUP, INC., a corporation organized and existing
under the laws of the State of Delware (the
"Company").
WHEREAS,
the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell
to the Investor,
from time to time as provided herein, and the Investor shall purchase
from the
Company up to Twenty Million Dollars ($20,000,000) of the Company's common
stock, no par value (the "Common Stock");
and
WHEREAS,
such investments will be made in
reliance upon the provisions of
Regulation D ("Regulation D") of the
Securities Act of 1933, as amended, and the
regulations promulgated thereunder (the "Securities Act"), and or upon such
other exemption from the registration
requirements of the
Securities Act as may
be available with respect to any or all of
the investments to be made hereunder.
WHEREAS,
the Company has
engaged Monitor
Capital Inc. (the "Placement
Agent"), to act as the Company's
exclusive placement agent in connection
with
the sale of the Company's Common Stock to
the Investor hereunder pursuant to the
Placement Agent Agreement dated the date hereof by and among
the Company, the
Placement Agent and the Investor (the
"Placement Agent Agreement").
NOW, THEREFORE,
the parties hereto agree as follows:
ARTICLE I.
Certain Definitions
Section 1.1.
"Advance"
shall mean the portion
of the Commitment
Amount
requested by the Company in the Advance
Notice.
Section 1.2.
"Advance Date" shall mean the date the David Gonzalez Attorney
Trust Account is in receipt of the funds
from the Investor and David Gonzalez,
Esq., is in possession of free trading
shares from the
Company and therefore an
Advance by the Investor to the Company can
be made and David Gonzalez, Esq. can
release the free trading shares to the Investor.
The Advance Date shall
be the
first (1st) Trading Day after expiration of the applicable Pricing Period for
each Advance.
Section 1.3.
"Advance Notice" shall mean a written
notice to the Investor
setting forth the Advance amount that the
Company requests from the Investor and
the Advance Date.
Section 1.4.
"Advance Notice Date" shall mean each date the Company
delivers to the Investor an Advance Notice requiring the Investor to advance
funds to the Company, subject to the terms of this
Agreement. No Advance Notice
Date shall be less than five (5)
Trading Days after the prior Advance Notice
Date.
<PAGE>
Section 1.5.
"Bid Price" shall mean, on any date, the closing bid price (as
reported by Bloomberg L.P.) of the Common Stock on the
Principal Market or if
the Common Stock is not traded on a
Principal Market,
the highest reported
bid
price for the Common Stock, as furnished by the National Association of
Securities Dealers, Inc.
Section 1.6.
"Closing" shall mean one of the closings of a purchase and
sale of Common Stock pursuant to Section
2.3.
Section 1.7.
"Commitment
Amount" shall mean the
aggregate amount of up to
Twenty Million Dollars ($20,000,000) which
the Investor has agreed to provide to
the Company in order to purchase
the Company's Common Stock pursuant to the
terms and conditions of this Agreement.
Section 1.8.
"Commitment
Period" shall mean the
period commencing on
the
earlier to occur of (i) the Effective Date, or (ii) such earlier date as the
Company and the Investor may mutually agree in writing, and expiring on the
earliest to occur of (x) the date on which
the Investor shall
have made payment
of Advances pursuant to this Agreement in
the aggregate amount of Twenty Million
Dollars ($20,000,000), (y) the date this Agreement is terminated
pursuant to
Section 2.4, or (z) the date occurring twenty-four (24) months after the
Effective Date.
Section 1.9.
"Common Stock" shall
mean the Company's
common stock, no par
value.
Section
1.10. "Condition Satisfaction Date" shall have the meaning set
forth in Section 7.2.
Section 1.11.
"Damages" shall mean any loss, claim, damage, liability,
costs and expenses (including, without limitation, reasonable attorney's fees
and disbursements and costs and expenses of
expert witnesses and investigation).
Section 1.12.
"Effective
Date" shall mean the
date on which the SEC first
declares effective a Registration Statement registering the resale of the
Registrable Securities as set forth in
Section 7.2(a).
Section 1.13.
"Escrow Agreement"
shall mean the escrow agreement among the
Company, the Investor, and David Gonzalez,
Esq., dated the date hereof.
Section 1.14.
"Exchange
Act" shall mean the
Securities
Exchange Act of
1934, as amended, and the rules and
regulations promulgated thereunder.
Section 1.15.
"Material
Adverse
Effect" shall mean any condition,
circumstance, or situation that would
prohibit or otherwise materially interfere
with the ability of the Company to enter
into and perform any of its obligations
under this Agreement or the Registration Rights Agreement in any material
respect.
Section 1.16.
"Market Price" shall mean the lowest VWAP of the Common Stock
during the Pricing Period.
2
<PAGE>
Section
1.17. "Maximum Advance Amount" shall be Five Hundred Thousand
Dollars ($500,000) per Advance Notice.
Section
1.18. "NASD" shall mean the National
Association
of Securities
Dealers, Inc.
Section
1.19. "Person" shall mean an individual, a corporation, a
partnership, an association, a trust or
other entity or organization, including
a government or political subdivision or an
agency or instrumentality thereof.
Section
1.20. "Placement Agent" shall mean Monitor Capital Inc., a
registered broker-dealer.
Section 1.21.
"Pricing Period" shall
mean the five (5) consecutive Trading
Days after the Advance Notice Date.
Section 1.22.
"Principal Market" shall mean the Nasdaq National Market, the
Nasdaq SmallCap Market, the American Stock Exchange,
the OTC Bulletin Board
or
the New York Stock Exchange, whichever is at the time the principal trading
exchange or market for the Common
Stock.
Section 1.23.
"Purchase Price" shall be set at ninety five percent (95%) of
the Market Price during the Pricing
Period.
Section 1.24.
"Registrable
Securities"
shall mean the shares of Common
Stock to be issued hereunder (i) in respect
of which the Registration Statement
has not been declared effective by the SEC, (ii) which
have not been sold under
circumstances meeting all of the applicable conditions of Rule 144 (or any
similar provision then in force) under the
Securities Act ("Rule 144") or (iii)
which have not been otherwise transferred to a holder who may
trade such shares
without restriction under the Securities Act, and the Company has delivered
a
new certificate or other evidence of
ownership for such securities not bearing a
restrictive legend.
Section 1.25.
"Registration
Rights Agreement"
shall mean the Registration
Rights Agreement dated the date hereof,
regarding the filing of the Registration
Statement for the resale of the Registrable
Securities, entered into between the
Company and the Investor.
Section 1.26.
"Registration
Statement" shall mean a registration statement
on Form S-1 or SB-2 (if use of such form is then available to the Company
pursuant to the rules of the SEC and, if
not, on such other form promulgated by
the SEC for which the Company then
qualifies and which counsel for the
Company
shall deem appropriate, and which form shall be available
for the resale of the
Registrable Securities to be registered thereunder in accordance with the
provisions of this Agreement and the Registration Rights Agreement, and in
accordance with the intended method of
distribution of such securities), for the
registration of the resale by the Investor
of the Registrable
Securities under
the Securities Act.
Section 1.27.
"Regulation
D" shall have the meaning set forth in the
recitals of this Agreement.
Section 1.28.
"SEC" shall mean the Securities and Exchange Commission.
3
<PAGE>
Section 1.29.
"Securities
Act" shall have the
meaning set forth in the
recitals of this Agreement.
Section 1.30.
"SEC Documents" shall mean Annual Reports on Form 10-KSB,
Quarterly Reports on Form 10-QSB, Current Reports on Form 8-K and Proxy
Statements of the Company as supplemented to the date hereof, filed by the
Company for a period of at least twelve
(12) months
immediately preceding
the
date hereof or the Advance Date, as the case may be, until such time as the
Company no longer has an obligation to maintain the effectiveness of a
Registration Statement as set forth in the
Registration Rights Agreement.
Section 1.31.
"Trading Day" shall mean any day during which the New
York
Stock Exchange shall be open for
business.
Section 1.32.
"VWAP" shall mean the
volume weighted
average price of
the
Company's Common Stock as quoted by
Bloomberg, LP.
ARTICLE II.
Advances
Section 2.1.
Investments.
------------
(a) Advances. Upon the terms and conditions set forth herein
(including, without limitation, the
provisions of Article VII hereof), on any
Advance Notice Date the Company may request
an Advance by the Investor by the
delivery of an Advance Notice. The number
of shares of Common Stock that the
Investor shall receive for each Advance
shall be determined by dividing the
amount of the Advance by the Purchase
Price. No fractional shares shall be
issued. Fractional shares shall be rounded
to the next higher whole number of
shares. The aggregate maximum amount of all
Advances that the Investor shall be
obligated to make under this Agreement
shall not exceed the Commitment Amount.
Section 2.2.
Mechanics.
----------
(a) Advance Notice.
At any time during the
Commitment
Period, the
Company may deliver an Advance Notice to
the Investor, subject to the conditions
set forth in Section 7.2; provided, however, the amount for each Advance as
designated by the Company in the applicable
Advance Notice, shall not be more
than the Maximum Advance Amount.
The aggregate amount
of the Advances
pursuant
to this Agreement shall not exceed the Commitment Amount. There shall be a
minimum of five (5) Trading Days between
each Advance Notice Date.
(b) Date of Delivery of Advance Notice. An Advance Notice shall be
deemed delivered on (i) the Trading Day it
is received by facsimile or otherwise
by the Investor if such notice is received
prior to 12:00 noon
Eastern Time, or
(ii) the immediately succeeding Trading Day if it is received by
facsimile or
otherwise after 12:00 noon Eastern Time on
a Trading Day or at any time on a day
which is not a Trading Day. No Advance
Notice may be deemed
delivered on a day
that is not a Trading Day.
4
<PAGE>
Section 2.3.
Closings. On each Advance Date, which shall be the first (1st)
Trading Day after expiration of the
applicable Pricing
Period for each Advance,
(i) the Company shall deliver to David Gonzalez, Esq. (the "Escrow Agent")
shares of the Company's Common Stock,
representing the
amount of the Advance by
the Investor pursuant to Section 2.1 herein, registered in the name of the
Investor which shall be delivered to the
Investor, or otherwise in accordance
with the Escrow Agreement and (ii) the Investor shall deliver to Escrow Agent
the amount of the Advance specified in the Advance
Notice by wire
transfer of
immediately available funds which shall be delivered to the Company, or
otherwise in accordance with the Escrow
Agreement. In
addition, on or prior
to
the Advance Date, each of the Company and the
Investor shall deliver to the
other through the Investor's counsel, all documents, instruments and writings
required to be delivered by either of them
pursuant to this
Agreement in order
to implement and effect the transactions
contemplated herein.
Payment of funds
to the Company and delivery of the
Company's Common Stock
to the Investor shall
occur in accordance with the conditions set forth
above and those
contained in
the Escrow Agreement; provided, however, that to the
extent the Company has not
paid the fees, expenses, and disbursements of the Investor, the Investor's
counsel, or the Company's counsel in
accordance with Section 12.4, the amount of
such fees, expenses, and disbursements may be deducted by the Investor
(and
shall be paid to the relevant party) from the amount of the
Advance with no
reduction in the amount of shares of the
Company's Common Stock
to be delivered
on such Advance Date.
Section 2.4.
Termination of
Investment. The
obligation of the Investor to
make an Advance to the Company pursuant to this Agreement shall terminate
permanently (including with respect to an Advance Date that has not yet
occurred) in the event that (i) there shall
occur any stop order or suspension
of the effectiveness of the Registration Statement for an aggregate of
fifty
(50) Trading Days, other than due to the acts of the
Investor, during the
Commitment Period, and (ii) the Company shall at any time fail
materially to
comply with the requirements of Article VI and
such failure is not cured within
thirty (30) days after receipt of written
notice from the
Investor, provided,
however, that this termination provision shall not apply to any period
commencing upon the filing of a
post-effective
amendment to such
Registration
Statement and ending upon the date on which
such post effective
amendment is
declared effective by the SEC.
Section 2.5.
Agreement to Advance Funds. The Investor agrees to advance the
amount specified in the Advance
Notice to the Company
after the completion
of
each of the following conditions and the other conditions set forth in this
Agreement:
(a) the execution and
delivery by the Company, and the Investor, of
this Agreement and the Exhibits hereto;
(b) The Company's Common Stock shall have been authorized for
quotation on the Principal Market.
(c) The Escrow Agent
shall have received
the shares of Common
Stock
applicable to the Advance in accordance with Section 2.3. Such shares
shall be
free of restrictive legends.
5
<PAGE>
(d) the Company's Registration Statement with respect to the resale
of
the Registrable Securities in accordance with the terms of the Registration
Rights Agreement shall have been declared
effective by the SEC;
(e) the Company shall have obtained all material permits and
qualifications required by any applicable state for the offer and sale of
the
Registrable Securities, or shall have the
availability of exemptions there from.
The sale and issuance of the Registrable
Securities shall be
legally permitted
by all laws and regulations to which the
Company is subject;
(f) the Company
shall have filed with the Commission in a timely
manner all reports, notices and other documents required of a "reporting
company" under the Exchange Act and
applicable Commission regulations;
(g) the fees as set forth in Section 12.4 below shall have been paid
or can be withheld as provided in Section
2.3; and
(h) the conditions set forth in Section 7.2 shall have been
satisfied.
(i) the Company shall have provided to the Investor an
acknowledgement
from its certified public accountants as to its ability to
provide all consents
required in order to file a registration statement in connection with this
transaction;
(j) The Company's transfer agent shall be DWAC eligible.
Section 2.6.
Lock Up
Period.
---------------
(a) On the date hereof, the Company shall obtain from each officer
and
director a lockup agreement in the form
annexed hereto as Schedule 2.6(a).
(b) In the event that the Company consummates a merger with a
publicly
traded entity, the Company shall obtain from each officer and
director of the
surviving entity a lockup agreement in the form annexed hereto as Schedule
2.6(b).
ARTICLE III.
Representations and Warranties of Investor
Investor
hereby represents and warrants to, and agrees with,
the Company
that the following are true and as of the date
hereof and as of each
Advance
Date:
Section
3.1. Organization and Authorization. The Investor is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority to
purchase and hold the securities issuable
hereunder. The
decision to invest and
the execution and delivery of this
Agreement by such Investor, the performance
by such Investor of its obligations hereunder and the consummation by such
Investor of the transactions contemplated hereby have been duly authorized
and
requires no other proceedings on the part of the
Investor. The
undersigned has
the right, power and authority to execute and deliver
this Agreement
and all
other instruments (including, without limitations, the Registration Rights
6
<PAGE>
Agreement), on behalf of the Investor. This
Agreement has been duly executed and
delivered by the Investor and, assuming the execution and delivery
hereof and
acceptance thereof by the Company,
will constitute the
legal, valid and binding
obligations of the Investor, enforceable
against the Investor in accordance with
its terms.
Section 3.2.
Evaluation
of Risks. The Investor has such knowledge and
experience in financial tax and business
matters as to be
capable of evaluating
the merits and risks of, and bearing the economic risks entailed by, an
investment in the Company and of protecting
its interests in connection
with
this transaction. It recognizes that its investment
in the Company
involves a
high degree of risk.
Section 3.3. No
Legal Advice From the
Company. The Investor
acknowledges
that it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with his or its
own legal counsel and investment
and tax advisors. The Investor is relying
solely on such counsel
and advisors
and not on any statements or representations of the Company or any of its
representatives or agents for legal, tax or investment advice with respect to
this investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.
Section 3.4.
Investment Purpose.
The securities are being purchased by the
Investor for its own account and for
investment purposes.
The Investor
agrees
not to assign or in any way transfer the
Investor's rights to
the securities or
any interest therein and acknowledges that the Company will not
recognize any
purported assignment or transfer except in
accordance with
applicable Federal
and state securities laws. No other person
has or will have a direct or indirect
beneficial interest in the securities. The Investor agrees not to sell,
hypothecate or otherwise transfer the Investor's securities unless the
securities are registered under Federal and applicable state
securities laws or
unless, in the opinion of counsel
satisfactory to the Company, an exemption from
such laws is available.
Section 3.5.
Accredited Investor.
The Investor is an "Accredited Investor"
as that term is defined in Rule 501(a)(3)
of Regulation D of the Securities Act.
Section 3.6.
Information. The
Investor and its advisors (and its counsel),
if any, have been furnished with all materials relating to the business,
finances and operations of the Company and
information
it deemed material to
making an informed investment decision.
The Investor and its
advisors, if any,
have been afforded the opportunity to ask questions of the Company and its
management. Neither such inquiries nor any other due
diligence
investigations
conducted by such Investor or its advisors,
if any, or its representatives shall
modify, amend or affect the Investor's right to rely on the Company's
representations and warranties contained in this Agreement. The Investor
understands that its investment
involves a high degree
of risk. The Investor is
in a position regarding the Company, which, based upon employment, family
relationship or economic bargaining power,
enabled and enables
such Investor to
obtain information from the Company in
order to evaluate the merits and risks of
this investment. The Investor has sought
such accounting, legal
and tax advice,
as it has considered necessary to make an informed
investment
decision with
respect to this transaction.
Section
3.7. Receipt of Documents. The Investor and its counsel has
received and read in their entirety: (i)
this Agreement and the Exhibits annexed
hereto; (ii) all due diligence and other information necessary to verify the
accuracy and completeness of such
representations, warranties and covenants; and
(iii) answers to all questions the Investor
submitted to the
Company regarding
an investment in the Company; and the Investor has relied on the
information
contained therein and has not been furnished
any other documents,
literature,
memorandum or prospectus.
7
<PAGE>
Section
3.8. Registration Rights Agreement and Escrow Agreement. The
parties have entered into the Registration Rights Agreement and the Escrow
Agreement, each dated the date hereof.
Section 3.9. No
General Solicitation.
Neither the Company,
nor any of its
affiliates, nor any person acting on its or their
behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of
Regulation D under the Securities
Act) in connection
with the offer or sale
of
the shares of Common Stock offered
hereby.
Section 3.10.
Not an Affiliate. The Investor is not an officer, director or
a person that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under
common control with the Company or any
"Affiliate" of the Company (as that term is defined in Rule 405 of the
Securities Act).
Section 3.11.
Trading Activities. The Investor's trading activities
with
respect to the Company's Common Stock shall
be in compliance with all applicable
federal and state securities laws, rules and regulations and the rules and
regulations of the Principal Market on which the Company's Common Stock is
listed or traded. Neither the Investor nor its affiliates has an open short
position in the Common Stock of the
Company, the Investor
agrees that it
shall
not, and that it will cause its
affiliates not to,
engage in any short sales of
or hedging transactions with respect to the Common
Stock, provided that the
Company acknowledges and agrees that upon receipt of an Advance Notice the
Investor has the right to sell the shares
to be issued to the Investor pursuant
to the Advance Notice during the applicable
Pricing Period.
Section 3.12. No
Investor makes any
representation or
warranty regarding
the Company's ability to successfully become a public company or to have any
registration statement filed by the Company
pursuant to the Registration Rights
Agreement or otherwise declared effective by the SEC. The Company
has the sole
obligation to make any and all such
filings as may be necessary to become a
public company and to have any registration
statement declared
effective by the
SEC.
ARTICLE IV.
Representations and Warranties of the Company
Except as stated
below, on the
disclosure
schedules attached hereto as
Exhibit B ("Disclosure Schedule"), the Company hereby represents and warrants
to, and covenants with, the Investor that the
following are true and correct as
of the date hereof:
Section
4.1. Organization and Qualification. The Company is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority
corporate power to own its properties and to
carry on its business as now being
conducted. Each of the Company and its subsidiaries is duly qualified as a
foreign corporation to do business and is
in good standing in every jurisdiction
8
<PAGE>
in which the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so
qualified or be in
good standing would not have a Material
Adverse Effect on the Company and its
subsidiaries taken as a whole.
Section 4.2.
Authorization, Enforcement, Compliance with Other Instruments.
(i) The Company has the requisite corporate power and authority to enter
into
and perform this Agreement, the Registration Rights Agreement, the Escrow
Agreement, the Placement Agent Agreement and any related agreements, in
accordance with the terms hereof and
thereof, (ii) the execution and delivery of
this Agreement, the Registration Rights Agreement, the Escrow Agreement, the
Placement Agent Agreement and any related agreements by the Company and the
consummation by it of the transactions contemplated hereby and thereby, have
been duly authorized by the Company's Board
of Directors and no further consent
or authorization is required by the Company, its Board of Directors or its
stockholders, (iii) this Agreement, the Registration Rights Agreement, the
Escrow Agreement, the Placement Agent Agreement and
any related agreements have
been duly executed and delivered by the Company, (iv) this Agreement, the
Registration Rights Agreement, the Escrow Agreement, the Placement Agent
Agreement and assuming the execution and
delivery thereof and
acceptance by the
Investor and any related agreements
constitute the valid and binding obligations
of the Company enforceable against the Company in accordance
with their terms,
except as such enforceability may be limited by
general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting
generally, the
enforcement of creditors'
rights and remedies.
Section 4.3.
Capitalization. As of
the date hereof, the authorized capital
stock of the Company consists of 100 shares of Common
Stock, no par value and
zero shares of Preferred Stock of which 100 shares of
Common Stock are
issued
and outstanding. All of such outstanding
shares have been validly issued and are
fully paid and nonassessable. Except as
disclosed in the Disclosure Schedule, no
shares of Common Stock are subject to preemptive rights or any other similar
rights or any liens or encumbrances
suffered or permitted by the Company. Except
as disclosed in the Disclosure Schedule, as
of the date hereof, (i) there are no
outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or
rights
convertible into, any shares of capital stock of the Company or any of its
subsidiaries, or contracts, commitments,
understandings or arrangements by which
the Company or any of its subsidiaries is or may become bound to issue
additional shares of capital stock of the
Company or any of its subsidiaries or
options, warrants, scrip, rights to subscribe to, calls or
commitments of any
character whatsoever relating to, or
securities or rights convertible into, any
shares of capital stock of the Company or any of its
subsidiaries,
(ii) there
are no outstanding debt securities
(iii) there are no
outstanding
registration
statements other than on Form S-8 and (iv) there are no agreements or
arrangements under which the Company or any of
its subsidiaries is obligated to
register the sale of any of their
securities
under the Securities Act (except
pursuant to the Registration Rights Agreement). There are no securities or
instruments containing anti-dilution or similar provisions that will be
triggered by this Agreement or any related
agreement or the
consummation of the
transactions described herein or therein. The Company has furnished to the
Investor true and correct copies of the
Company's Certificate
of Incorporation,
as amended and as in effect on the date hereof (the "Certificate of
Incorporation"), and the Company's By-laws,
as in effect on the date hereof (the
"By-laws"), and the terms of all securities
convertible into or exercisable for
Common Stock and the material rights of the
holders thereof in respect thereto.
9
<PAGE>
Section 4.4. No
Conflict. The
execution, delivery
and performance of this
Agreement by the Company and the
consummation by the Company of the transactions
contemplated hereby will not (i) result in a
violation of the
Certificate
of
Incorporation, any certificate of designations of any outstanding series of
preferred stock of the Company or By-laws or
(ii) conflict with or constitute a
default (or an event which with notice or lapse of time
or both would become
a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any
agreement, indenture or instrument to which
the Company or any of its subsidiaries is a party, or result in a
violation of
any law, rule, regulation, order, judgment or decree (including federal and
state securities laws and regulations and the rules and regulations of the
Principal Market on which the Common Stock
is quoted) applicable
to the Company
or any of its subsidiaries or by which any material property or asset of the
Company or any of its subsidiaries is bound or affected
and which would cause a
Material Adverse Effect. Except as
disclosed in the Disclosure Schedule, neither
the Company nor its subsidiaries is in violation of any term of or in
default
under its Articles of Incorporation or
By-laws or their
organizational
charter
or by-laws, respectively, or any material contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree or
order or any statute,
rule or regulation applicable to the Company or its
subsidiaries. The
business
of the Company and its subsidiaries is not being conducted in
violation of any
material law, ordinance, regulation of any governmental entity. Except as
specifically contemplated by this Agreement
and as required under the Securities
Act and any applicable state securities laws, the Company is not required
to
obtain any consent, authorization or order of, or make any filing or
registration with, any court or
governmental agency in
order for it to execute,
deliver or perform any of its obligations under or contemplated by this
Agreement or the Registration Rights Agreement in accordance with the terms
hereof or thereof. All consents, authorizations, orders, filings and
registrations which the Company is required to
obtain pursuant to the preceding
sentence have been obtained or effected on or prior to the date
hereof. The
Company and its subsidiaries are unaware of
any fact or circumstance which might
give rise to any of the foregoing.
Section
4.5. Financial Statements. As of their respective dates, the
financial statements of the Company (the
"Financial
Statements")
for the two
most recently completed fiscal years and any
subsequent interim period complied
as to form in all material respects with
applicable accounting
requirements and
the published rules and regulations of the SEC with respect thereto. Such
financial statements have been prepared in
accordance with
generally accepted
accounting principles, consistently
applied, during the periods involved (except
(i) as may be otherwise indicated in such financial statements or the notes
thereto, or (ii) in the case of unaudited
interim statements, to the extent they
may exclude footnotes or may be condensed or
summary statements)
and, fairly
present in all material respects the
financial position of the Company as of the
dates thereof and the results of its
operations
and cash flows for the
periods
then ended (subject, in the case of unaudited
statements,
to normal year-end
audit adjustments). No other information
provided by or on behalf of the Company
to the Investor contains any untrue statement of